Ventilator‐associated pneumonia (VAP) is one of the most common hospital-acquired infections, especially among critically ill patients. While many doctors turn to antimicrobials to combat VAP, this is often irresponsible, given the efficacy of treatments such as chlorhexidine.

VAP results from the microbial invasion of the normally sterile lower respiratory tract, which subsequently can overwhelm the host’s defense and establish infection.

Please sign in to read more